Potentially leading to the fermentation of food and the production of sulfur gases
Despite the damaged components of G6PD-deficient red cells that are likely to confer unfavorable rheological properties and increased agglutinability, an early article reported that G6PD-deficient erythrocytes have enhanced flexibility probably due to the higher level of unsaturated fatty acids [134]
While current research, including case studies and clinical trials, describes potential for experiencing severe adverse psychiatric symptoms such as anxiety, depression, suicidal ideation, and personality changes after initiating GLP-1 receptor agonist treatment, some research suggests that the use of these drugs did not increase psychiatric problems
Resmetirom's mechanisms of action include increased fatty acid -oxidation, reduced hepatic de novo lipogenesis, and enhanced clearance of plasma atherogenic lipoproteins, thereby targeting key pathways involved in MASH development (Petta et al., 2024[60])
